Skip to content

Support programme to improve wellbeing in family caregivers of children, adolescents and young adults receiving palliative or end-of-life care

A multinational, randomized-controlled, parallel-group, open-label clinical study to evaluate the effectiveness of a comprehensive patient and family-centred intervention (PALLIAKID Intervention) to improve the wellbeing of family caregivers of children, adolescents and young adults in need of palliative and/or end-of-life care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12831769
Enrollment
310
Registered
2026-02-13
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative care needs in children, adolescents and young adults, and caregiver burden and wellbeing among their family caregivers Other

Interventions

The study consists of two arms: an intervention arm receiving the PALLIAKID Intervention in addition to standard paediatric palliative care, and a control arm receiving standard care only. Participant
randomisation is generated through the IDAS system and implemented in the electronic case report form (eCRF). Participants in this arm receive usual paediatric palliative care plus a multicomponent i

Sponsors

Fundació Privada per a la Recerca i la Docència Sant Joan de Déu (FSJD-CERCA)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 19 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for family caregivers: 1. Family caregivers of a patient (aged =0 years and <20 years at study start, of any gender) affected by a non-oncologic life-limiting or life-threatening disease, and referred to a paediatric palliative care team of the site 2. Ability to speak, read and understand in either of the official languages of the country or English 3. With access to an internet connection and mobile device (e.g., smartphone or tablet) 4. Signed informed consent form. The consent from parent(s)/guardian(s) will be obtained following the rules of the specific countries Inclusion criteria for patients: 1. Patients aged =6 years and <20 years at study start, of any gender 2. Affected by a non-oncologic life limiting or life-threatening disease 3. Currently receiving care by/referred to a paediatric palliative care team at one of the participating clinical sites 4. Appropriate communication skills in either of the official languages of the country or English 5. With access to an internet connection and mobile device (e.g., smartphone or tablet) 6. Signed informed consent form for patients older than 18 years old and signed informed assent for patients, when required, according to the rules of the specific countries Inclusion criteria for siblings: 1. Children and Adolescents and Young Adults (AYAs) aged =6 years and <20 years at study start, of any gender 2. Appropriate communication skills in either of the official languages of the country or English 3. With access to an internet connection and mobile device (e.g., smartphone or tablet) 4 .Signed informed consent for participants older than 18 years old and signed informed assent for participants younger than 18 years old, when required, according to the rules of the specific countries Inclusion criteria for healthcare professionals: Any health professional being part of the paediatric palliative care team of the participant site working with patients (aged =0 years and <20 years at study start, of any gender) affected by a nononcologic life-limiting or life-threatening disease.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients, siblings, and family caregivers: Anyone who is not able to participate in the study according to the clinical judgement of the site chief investigator or any other authorised person of the research team if deemed that participation could be harmful. This judgement has to be documented in writing for each child/parent not being enrolled.

Countries

Denmark, Finland, Italy, Latvia, Spain

Contacts

Public ContactSergi Navarro Villarrubí
sergi.navarro@sjd.es+34 (0)932 53 21 00

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026